advertisement

---

Pirich C 1

Showing records 1 to 1 | Display all abstracts from Pirich C

100377 Assessment of Treatment Response to Lenvatinib in Thyroid Cancer Monitored by F-18 FDG PET/CT Using PERCIST 1.0, Modified PERCIST and EORTC Criteria-Which One Is Most Suitable?
Rendl G; Schweighofer-Zwink G; Sorko S; Gallowitsch HJ; Hitzl W; Reisinger D; Pirich C
Cancers 2022; 14:

---